WAPNICK PAMELA (Chief Financial Officer) sold 1.4% of their position (2.88K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/10/2026ACC: 0001193125-26-265335
Officer· Chief Financial Officer
Since Mar 2026
-2.88K
Net shares
Net seller
$3.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.88K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.88K
Price / share
$1.30
Trade value
$3.75K
% of position
1.4%
6/5/2026
211.38K→208.49K
Total
Net shares
−2.88K
Net value
-$3.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2026 | S · Sale | −2.88K | $1.30 | $3.75K | 1.4% | 211.38K | 208.49K |
| Total | −2.88K | -$3.75K | ||||||
Derivative Transactions0
No derivative transactions reported